Effects of dry cow treatment of beef cows on pathogenic organisms, milk somatic cell counts, and calf growth during the subsequent lactation.
Spring calving Angus and Angus x Hereford multiparous cows were utilized to determine the effects of intramammary treatment with penicillin G procaine (200,000 IU) and novobiocin (400 mg) at the time of weaning on udder health and calf growth after the subsequent calving. Cows were stratified by age and breed and assigned randomly to receive intramammary treatment (n = 99) at weaning or as untreated controls (n = 97). Quarter milk samples were collected at weaning and at 8 to 14 d after calving. Milk samples were analyzed for somatic cell counts (SCC) and mastitis-causing bacteria. Dry cow treatment decreased (P = 0.005) the number of cows infected after calving. Treatment decreased (P = 0.04) the number of cows that developed new infections and reduced (P = 0.03) the number of quarters with mastitis-causing bacteria after calving that were infected at weaning. Somatic cell counts after calving were greatest (P = 0.008) for cows infected with Staphylococcus aureus. Treatment did not alter (P = 0.19) SCC of quarters after calving that were infected with S. aureus at weaning but reduced (P = 0.002) SCC after calving of quarters that were infected with coagulase-negative staphylococci at weaning. Body weight of calves during early lactation was increased (P = 0.006) if cows with intramammary infection were treated at weaning. Treatment of noninfected cows at weaning increased (P = 0.008) adjusted 205-d weaning weights of calves after the subsequent lactation when compared with untreated noninfected cows. We conclude that treatment of beef cows at weaning with intramammary antibiotics decreased intramammary infections after calving, improved udder health during the subsequent lactation, and increased BW gain of the calves.
Lents
C A
CA
Department of Animal Science, Oklahoma Agricultural Experiment Station, Stillwater, OK 74078, USA.
Wettemann
R P
RP
Paape
M J
MJ
Looper
M L
ML
Buchanan
D S
DS
D000818:Animals; D000833:Animals, Suckling / Q000254:growth & development*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002417:Cattle; D005260:Female; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D007774:Lactation; D016018:Least-Squares Analysis; D008321:Mammary Glands, Animal / Q000382:microbiology; D008414:Mastitis, Bovine / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology / Q000517:prevention & control; D008892:Milk / Q000166:cytology* / Q000382:microbiology; D009675:Novobiocin / Q000008:administration & dosage / Q000494:pharmacology; D010402:Penicillin G Procaine / Q000008:administration & dosage / Q000494:pharmacology; D011897:Random Allocation; D014886:Weaning; D015430:Weight Gain / Q000187:drug effects
D000900:Anti-Bacterial Agents; D009675:Novobiocin; D010402:Penicillin G Procaine